Key Financial Data Of Reporting Company

Daito Pharmaceutical Co., Ltd. - Filing #7362493

Concept 2023-09-01 to
2023-11-30
As at
2023-11-30
2023-06-01 to
2023-11-30
As at
2023-05-31
2022-06-01 to
2023-05-31
2022-09-01 to
2022-11-30
2022-06-01 to
2022-11-30
As at
2022-11-30
Key financial data of reporting company
Business results of reporting company
Net sales
24,110,000,000 JPY
45,101,000,000 JPY
23,367,000,000 JPY
Ordinary profit (loss)
2,314,000,000 JPY
5,169,000,000 JPY
2,752,000,000 JPY
Net assets
52,122,000,000 JPY
50,971,000,000 JPY
49,530,000,000 JPY
Total assets
74,990,000,000 JPY
70,552,000,000 JPY
71,124,000,000 JPY
Basic earnings (loss) per share
54.95
98.22
227.63
56.75
111.33
Diluted earnings per share
227.42
111.13
Equity-to-asset ratio
0.692 xbrli:pure
0.718 xbrli:pure
0.691 xbrli:pure
Net cash provided by (used in) operating activities
1,946,000,000 JPY
4,155,000,000 JPY
1,141,000,000 JPY
Net cash provided by (used in) investing activities
-3,616,000,000 JPY
-5,566,000,000 JPY
-1,545,000,000 JPY
Net cash provided by (used in) financing activities
2,609,000,000 JPY
616,000,000 JPY
1,871,000,000 JPY
Cash and cash equivalents
4,585,000,000 JPY
3,607,000,000 JPY
5,882,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.